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Background/aim: The purpose of this study is to compare the diagnostic value of hepcidin level with the white blood cell (WBC),
C-reactive protein (CRP), procalcitonin (PCT), and interleukin-6 (IL-6) levels in pediatric sepsis and septic shock.
Materials and methods: A cohort of 89 individuals were divided into four groups: a healthy control group (HCG, n = 28), pediatric
intensive care unit control group (PICUCG, n = 17), sepsis group (SG, n = 23), and septic shock group (SSG, n = 21). WBC, CRP, PCT,
IL-6, and hepcidin levels were studied in the PICUCG, SG, and SSG, while hepcidin and IL-6 levels were studied in the HCG.
Results: In distinguishing the SG and SSG from the HCG, hepcidin sensitivity and specificity were found to be 100%. Distinguishing
between the PICUCG and the SG, hepcidin sensitivity was calculated as 95.6% and specificity was calculated as 100%. The sensitivity of
WBC, CRP, and PCT was lower than that of hepcidin, but the sensitivity of IL-6 was higher than that of hepcidin. While the specificity
of PCT and IL-6 was the same as hepcidin, the specificity of WBC and CRP was lower than that of hepcidin.
Conclusion: Hepcidin is a more reliable indicator than WBC and CRP levels in distinguishing children with sepsis and septic shock
from healthy children and nonseptic pediatric ICU patients.
Key words: C-reactive protein, hepcidin, interleukin-6, procalcitonin, sepsis, septic shock

1. Introduction
Sepsis is a systemic, excessive, uncontrolled, and
deleterious host response syndrome that is associated with
a documented or suspected infection with the systemic
inflammatory response syndrome (1). Despite improved
understanding of the pathophysiology, advanced intensive
care technology, and available pharmacological therapies,
sepsis remains the most common cause of morbidity and
mortality in infants and children worldwide (2). It can
rapidly progress to septic shock, multiorgan failure, and
death if treatment is delayed. Therefore, early identification
of sepsis and prompt intervention are cornerstones to
reduce the morbidity and mortality. For all of these
reasons, recent clinical trials focused on new biochemical
markers in order to increase early recognition of sepsis (3).
Hepcidin, synthesized in hepatocytes and the master
hormonal regulator of iron metabolism, is an antimicrobial
peptide and acute-phase reactant. Synthesis of hepcidin is
regulated by interleukin-6 (IL-6) and lipopolysaccharide
in inflammatory and infectious situations (4,5). It
* Correspondence: cağlaes@yahoo.com

binds to the iron exporter ferroportin and promotes its
internalization and lysosomal degradation in target cells,
especially macrophages, enterocytes, and hepatocytes.
As a result, the excessive hepcidin synthesis causes
hypoferremia by inhibiting dietary iron absorption and
enhancing intracellular iron sequestration (6). Hepcidin
has direct antimicrobial activity and it contributes to host
defense by depriving microorganisms of this essential iron
mineral (6,7). The use of hepcidin as an adjunct test for
sepsis has been detected in adults, as well as in term and
preterm neonates (8,9).
The aim of this prospective cross-sectional study is
to compare the diagnostic value of hepcidin with wellestablished biochemical markers such as white blood cell
(WBC), C-reactive protein (CRP), procalcitonin (PCT),
and IL-6 levels in pediatric sepsis and septic shock.
2. Materials and methods
This prospective cross-sectional study was conducted
between June 2015 and July 2016 at the University of
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Health Sciences Bakırköy Dr. Sadi Konuk Research and
Training Hospital in Turkey. A total of 89 individuals,
61 pediatric patients hospitalized in a 9-bed pediatric
intensive care unit (PICU) and 28 healthy children
routinely examined at a pediatric outpatient clinic, were
included in the study. The study was initiated following
the approval of the Bakırköy Dr. Sadi Konuk Research and
Training Hospital Ethics Committee (approval number:
2015/08/06; approval date: 11 May 2015). The individuals
were divided into four groups: healthy control group
(HCG), PICU control group (PICUCG), sepsis group
(SG), and septic shock group (SSG). Pediatric sepsis and
septic shock were defined according to international
guidelines (1). The PICUCG was composed of nonseptic
patients who were followed up in the PICU. Informed
consent was obtained from patients’ parents or legal
guardian. In the PICUCG, SG, and SSG, CRP, WBC, PCT,
IL-6, and hepcidin levels were studied in the remaining
blood serum sample taken for routine laboratory tests
immediately after admission to the PICU. In the healthy
children, venous blood samples were collected in tubes
from the antecubital vein for routine laboratory tests
followed by overnight fasting. Hepcidin and IL-6 were
studied in the remaining blood serum sample taken from
the healthy children. The tubes were centrifuged at 2000 ×
g (10 min) to remove the serum. The serum samples were
kept at –80 °C until analysis of hepcidin and IL-6. Serum
levels of hepcidin and IL-6 were assessed by the enzymelinked immunosorbent assay (ELISA) technique. Serum
hepcidin and IL-6 levels were determined using a Human
Hepcidin ELISA kit (catalog no: CK-E90190) purchased
from Eastbiopharm (China) and a Human IL-6 ELISA
kit (catalog no: 950.030.192) purchased from Diaclone
(France) following the manufacturer’s instructions.
Serum levels were expressed as ng/mL. The intra- and
interassay coefficients of variation were 7.9% and 4.2%
and 8.1% and 7.7%, respectively. Serum PCT and CRP
levels were determined by the Roche Cobas 8000 ClinicalImmunochemistry Integrated Automation System using
commercial kits (Roche Diagnostics, USA). Hematological
tests for WBC count was performed using the Abbott CellDyn Ruby analyzer (Abbott Diagnostics, USA).
All statistical analyses were performed using IBM
SPSS for Windows, version 20.0 (IBM Corp., Armonk,
NY, USA). Kolmogorov–Smirnov tests were used to test
the normality of data distribution. Continuous variables
were expressed as mean ± standard deviation and median
(25th–75th percentiles), and categorical variables were
expressed as counts (percentages). Differences between
the groups were analyzed by one-way ANOVA and Tukey
post hoc test, Kruskal–Wallis one-way ANOVA, and Dunn
post hoc test for numerical variables with normal and
abnormal distribution while the Monte Carlo chi-square
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test was used for categorical variables. The relationship
between numerical variables was evaluated by Spearman
correlation analysis. Receiver operating curve (ROC)
analysis was performed to determine the sensitivity and
the specificity of different cutoff points for WBC, CRP,
PCT, IL-6, and hepcidin to predict sepsis and septic shock.
The most appropriate cutoff point was chosen according to
the ROC analysis and the area under the curve (AUC) was
calculated. P < 0.05 was considered statistically significant.
3. Results
The mean age of participants was 46.7 ± 37.4 months. Of
them, 53 (59.6%) were male and 36 (40.4%) were female.
There was a significant difference between the groups
in terms of the mean age (P = 0.04). As a result of the
binary comparisons made to determine the difference, the
mean age of the HCG was statistically and significantly
higher than that of the SG and SSG (P < 0.05). There was
no significant difference in the mean age between the
PICUCG, SG, and SSG (P = 0.18). There was no significant
difference between the groups in terms of sex (P = 0.21).
The diagnosis distribution of the pediatric intensive care
unit control group is shown in Table 1. Distribution of the
causative organisms in the sepsis and septic shock group is
shown in Table 2.
There was a significant difference between the groups
in terms of the WBC, CRP, PCT, IL-6, and hepcidin levels
(respectively P = 0.029, P = 0.001, P = 0.003, P < 0.001, and
P < 0.001) (Table 3). As a result of the binary comparisons
made to determine the difference, hepcidin and IL-6
levels were significantly lower in the HCG compared to
the PICUCG, SG, and SSG (P < 0.05, Table 3). Hepcidin,
WBC, CRP, PCT, and IL-6 levels were significantly lower
in the PICUCG compared to the SG and SSG (P < 0.05,
Table 3). There was no significant difference between
the SG and SSG in terms of the WBC, CRP, PCT, ILTable 1. The diagnoses of the pediatric intensive care unit control
group.
Patients’ diagnoses (n: 17)

Number (%)

Trauma

6 (35.29)

Pneumonia

3 (17.64)

Hemolytic uremic syndrome

2 (11.76)

Intoxication

1 (5.88)

Intracranial mass

1 (5.88)

Metabolic disease

1 (5.88)

Guillain–Barre syndrome

1 (5.88)

Fulminant autoimmune hepatitis

1 (5.88)

Status epilepticus

1 (5.88)
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Table 2. Distribution of causative organisms in the sepsis and septic shock group.
Sepsis (n: 23)
Methicillin-resistant coagulase negative staphylococci (blood)
Acinetobacter baumannii (tracheal aspirate)
Methicillin-sensitive coagulase negative staphylococci (CSF)
Methicillin-sensitive coagulase negative staphylococci (tracheal aspirate)
Pseudomonas aeruginosa (tracheal aspirate)
Streptococcus pneumonia (CSF)
Neisseria meningitis (serum-PCR)
Cytomegalovirus (serum-PCR)
Influenza A virus (nasopharyngeal aspirate-PCR)
Total

3
2
1
1
1
1
1
1
1
12 (52.17%)

Septic shock (n: 21)
Pseudomonas aeruginosa (tracheal aspirate)
Pseudomonas aeruginosa (blood)
Klebsiella pneumoniae (tracheal aspirate)
Neisseria meningitis (serum-PCR)
Leptospirosis (positivity of serum IgG and IgM))
Total

1
1
1
1
1
5 (23.8%)

CSF: Cerebrospinal fluid, PCR: polymerase chain reaction.

6, and hepcidin levels (P > 0.05, Table 3). The point
distribution of the hepcidin levels in the groups is shown
in Figure 1. A statistically significant correlation was
observed between hepcidin and Pediatric Risk of Mortality
(PRISM) III score (r = 0.588, P < 0.001) and also between
hepcidin and IL-6 (r = 0.757, P < 0.001) (Figure 2).
Correlation of the biomarkers between each other and the
correlation between biomarkers and the PRISM III score
are shown in Table 4.
According to the ROC analysis, when the cutoff value
for hepcidin was determined to be 18.8 ng/mL according
to the healthy children, its sensitivity and specificity for a
diagnosis of sepsis and septic shock were found to be 100%
(Figure 3). When the cutoff value for IL-6 was determined
to be 0.02 ng/mL according to the healthy children, its
sensitivity and specificity for a diagnosis of sepsis and
septic shock were the same as that reported for hepcidin
(100%). The cutoff value for hepcidin was determined to
be 54.3 ng/mL in distinguishing between the PICUCG
and the SG. The sensitivity and specificity for this value
were calculated as 95.6% and 100%, respectively (Table 5;
Figure 3). In distinguishing between these two groups, the
sensitivity of WBC, CRP, and PCT levels was lower than
that of hepcidin (respectively 78.2%, 78.2%, and 60.8%),
but the sensitivity of IL-6 was higher than that of hepcidin
(100%). While the specificity of PCT and IL-6 was the same
as that of hepcidin (100%), the specificity of WBC and
CRP levels was lower than that of hepcidin (respectively
58.8% and 82.3%) (Table 5). The cutoff value for hepcidin

level was determined to be 54.3 ng/mL in distinguishing
between the PICUCG and the SSG. The sensitivity and
specificity for this value were calculated as 100% and 100%,
respectively (positive predictive value = 100%, negative
predictive value = 100%) (Figure 3). In distinguishing
between these two groups, the sensitivity and specificity of
IL-6 were the same as that of hepcidin. The sensitivity and
specificity of WBC count and CRP were lower than that of
hepcidin (respectively, sensitivity/specificity: 71.4%/70.6%
and 76.2%/82.3%). While the sensitivity of PCT was lower
than that of hepcidin (71.4%), the specificity of PCT was
the same as that of hepcidin (100%).
4. Discussion
In humans, high levels of hepcidin were detected
in patients with inflammatory diseases and chronic
infections. Among the cytokines, IL-6, but not tumor
necrosis factor α or IL-1α, strongly stimulates hepcidin
mRNA synthesis. Sepsis and septic shock are prototypical
acute and excessive inflammatory situations. In recent
studies, the hepcidin level was higher in adult septic
patients compared to healthy individuals and nonseptic
ICU patients (6,8,10–12). As a result of our study, hepcidin
levels were found to be significantly higher in the patients
with sepsis and septic shock compared to both the
healthy children and the nonseptic PICU patients. While
the sensitivity and specificity of hepcidin were 100% in
distinguishing the children with sepsis from the healthy
children, its sensitivity and specificity were respectively
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Table 3. The characteristics of the study population groups.
Patients’
characteristics and
serum markers

Healthy
controls (n: 28)

Pediatric intensive
care unit control
(n: 17)

3
Sepsis
(n: 23)

4
Septic shock
(n: 21)

P

Age (months),
mean ± SD

58.78 ± 28.78

56.35 ± 35.55

34.52 ± 40.97

36.24 ± 40.34

0.04a

Male sex, n (%)

17 (60.7%)

13 (76.5%)

14 (60.9%)

9 (42.9%)

0.338b

PRISM III, median
(25th-75th
percentiles)

0 (0–8)

12 (8–17)

25 (16–29)

<0.001

WBC count
(/mm3)

9.7 (6.85–12.7)

16.6 (10.6–29.6)

13.6 (7.8–21.5)

0.029

CRP,
mg/dL

0.2 (0.065–0.3)

2.1 (0.4–5)

3.4 (0.35–11.3)

0.001c

PCT,
ng/dL

0.2 (0.075–0.45)

1.6 (0.1–9.2)

8.1 (0.15–60)

0.003c

IL-6,
ng/mL

Hepcidin,
ng/mL

1

2

Pd

c

P2-3: 0.01
P2-4: <0.001
P3-4: 0.002
P2-3: 0.01
P2-4: 0.047
P3-4: 0.55
P2-3: 0.002
P2-4: <0.001
P3-4: 0.53
P2-3: 0.014
P2-4: 0.001
P3-4: 0.31

0.013 (0.010–0.017) 0.026 (0.021–0.057) 0.167 (0.127–0.188) 0.177 (0.130–0.225) <0.001c

P1-2: 0.013
P1-3 <0.001
P1-4: <0.001
P2-3: <0.001
P2-4: <0.001
P3-4: 0.67

16 (15.6–16.5)

P1-2: 0.015
P1-3: <0.001
P1-4: <0.001
P2-3: 0.001
P2-4: <0.001
P3-4: 0.24

31.2 (23–37.7)

155.5 (144.7–221.1) 198.2 (165.1–258.6) <0.001c

One-way ANOVA, b chi-square test, c Kruskal–Wallis test, d Dunn post hoc test.
Data are expressed as mean ± SD for age and as median (IQR) for WBC, CRP, PCT, IL-6, and hepcidin levels.
WBC: White blood cell, CRP: C-reactive protein, PCT: procalcitonin, IL-6: interleukin-6
a

95.6% and 100% in distinguishing the children with sepsis
from the nonseptic PICU patients (Table 5; Figure 3). In
distinguishing the children with sepsis from the nonseptic
PICU patients, while only the sensitivity of IL-6 was higher
than that of hepcidin, the specificity of PCT and IL-6 was
the same as that of hepcidin (100%). The sensitivity and
specificity of WBC and CRP levels for a diagnosis of sepsis
were found to be lower than that of hepcidin (Table 5).
In our study, there was no significant difference between
the SG and SSG in terms of the values of hepcidin and all
other markers (Table 3). Studies showing the relationship
between hepcidin and sepsis in children were performed
in the neonatal patient population (9,13). Cizmeci et al.
(9) showed that the range of cord blood hepcidin was
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found to be significantly increased in 38 newborns with
early-onset neonatal sepsis compared to healthy controls.
Unlike our study, they did not compare hepcidin with
other sepsis markers. Wu et al. (13) observed that hepcidin
level was four times greater in 17 newborns with late-onset
neonatal sepsis compared to healthy controls. Similarly, in
this study, the sensitivity and specificity of hepcidin for a
diagnosis of sepsis were found to be higher than that of
CRP. To the best of our knowledge, our study is the first
study to investigate the relationship between hepcidin
and sepsis in children except for the newborn period. In
addition, the comparison of WBC, CRP, PCT, IL-6, and
hepcidin values in a diagnosis of sepsis and septic shock is
very important.

YEŞİLBAŞ et al. / Turk J Med Sci

Figure 1. The distribution of hepcidin levels (ng/mL) in the groups.

Figure 2. Correlation between hepcidin and PRISM III score. PRISM III: Pediatric Risk
of Mortality III.
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Table 4. Correlation of the biomarkers between each other and correlation between biomarkers and Pediatric Risk of Mortality III score.
Parameters
WBC (/mm3)
CRP (mg/dL)
PCT (ng/dL)
IL-6 (ng/mL)
Hepcidin (ng/mL)
PRISM III

r
P
r
P
r
P
r
P
r
P
r
P

WBC
(/mm3)
0.108
0.407
0.013
0.919
0.372
0.003
0.217
0.093
–0.048
0.711

CRP
(mg/dL)
0.108
0.407
0.536
<0.001
0.321
0.012
0.379
0.003
0.415
0.001

PCT
(ng/dL)
0.013
0.919
0.536
<0.001
0.308
0.016
0.338
0.008
0.480
<0.001

IL-6
(ng/mL)
0.372
0.003
0.321
0.012
0.308
0.016
0.757
<0.001
0.582
<0.001

Hepcidin
(ng/mL)
0.217
0.093
0.379
0.003
0.338
0.008
0.757
<0.001
0.588
<0.001

PRISM III
–0.048
0.711
0.415
0.001
0.480
<0.001
0.582
<0.001
0.588
<0.001

WBC: White blood cell, CRP: C-reactive protein, PCT: procalcitonin, IL-6: interleukin-6, PRISM III: Pediatric Risk of Mortality III.

Figure 3. The diagnosis of sepsis and septic shock for hepcidin according to receiver operating curve (ROC) analysis. A) Sepsis group
versus healthy control group [area under the curve (AUC) = 1.000], B) septic shock group versus healthy control group (AUC = 1.000),
C) sepsis group versus pediatric intensive care unit control group (AUC =0.995), D) septic shock group versus pediatric intensive care
unit control group (AUC = 1.000).
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Table 5. According to receiver operating curve analysis, the cutoff, sensitivity, specificity, and positive and negative predictive values
of hepcidin and other serum markers in distinguishing between the pediatric intensive care unit control group and the sepsis group.
Diagnostic scan
Serum markers

Cutoff

Sens

ROC curve
Spec

PPV

NPV

AUC

95% CI

P

WBC (/mm3)

10.2

78.26

58.82

72.0

66.7

0.738

0.575–0.864

<0.01

CRP (mg/dL)

0.3

78.26

82.35

85.7

73.7

0.812

0.657–0.918

<0.01

PCT (ng/dL)

1.27

60.87

100

100

65.4

0.752

0.590–0.875

<0.01

IL-6 (ng/mL)

0.712

100

100

100

100

1.000

0.912–1.000

<0.01

Hepcidin (ng/mL)

54.3

95.65

100

100

94.4

0.995

0.902–1.000

<0.01

WBC: White blood cell, CRP: C-reactive protein, PCT: procalcitonin, IL-6: interleukin-6., Sens: sensitivity, Spec: specificity, PPV:
positive predictive value, NPV: negative predictive value, AUC: area under the curve, CI: confidence interval.

In distinguishing between sepsis and noninfective
causes of inflammation in children and adults, the results
of our study are consistent with the literature in that the
specificity of PCT was higher than that of CRP, but they
differ from the literature in that the sensitivity of CRP was
higher than that of PCT (14–18). It was found in many
child and adult studies that sepsis severity was associated
with PCT and IL-6 but not associated with CRP (15,17,19–
24). The results of our study were consistent with the
literature in terms of CRP, but differ from the literature in
that there was no significant difference between PCT and
IL-6 in distinguishing between sepsis and septic shock.
The limitations of our study are primarily that the
number of patients was low and the mean age of the
healthy children was significantly higher than that of other
groups. Moreover, we were not able to examine WBC, CRP,
and PCT levels due to inadequate blood volume collected
from the healthy children. The levels of the biomarkers
at the time the samples were taken may not reflect their
actual levels because our data are cross-sectional, the
half-lives of sepsis markers are different (14,25–27), and
the majority of patients had received antibiotic and fluid
therapy prior to the PICU. Hepcidin is severely affected by
anemia parameters such as serum and storage iron levels

of patients regardless of the level of inflammation. Body
weight and body mass index are very important factors
affecting hepcidin and the levels of other biochemical
markers (28,29). These factors were not compared between
the groups in our study. In addition, various factors such as
acute kidney injury, liver injury, nutritional status, severity
of illness, treatment approaches, and other comorbidities,
which are likely to influence hepcidin and other biomarker
levels, were not evaluated in our study.
In conclusion, our study has showed that hepcidin is
a more reliable indicator than WBC count and CRP in
distinguishing children with sepsis and septic shock from
healthy children and nonseptic PICU patients. However, it
is not reliable in distinguishing between sepsis and septic
shock in children. Although our study does not provide
any new pathway of the sepsis pathophysiology or any new
change to our clinical management, we think that there is a
need for more comprehensive studies on this subject.
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